Ying Tam, M.Sc., Ph.D. - Acuitas
WEBChief Scientific Officer of Acuitas Therapeutics, Dr. Ying K. Tam, is a globally respected expert in the areas of nanotechnology and immunology.
Dr. Ying Tam Talks Academia, Industry, and Career Paths
WEBSep 6, 2017 · Dr. Ying Tam is the Director of Preclinical Development at Acuitas Therapeutics, a Vancouver-based pharmaceutical company specializing in systemic delivery of nucleic acid therapeutics.
Ying TAM | Director, Preclinical Studies | BSc, MSc, PhD
WEBYing TAM, Director, Preclinical Studies | Cited by 12,777 | | Read 174 publications | Contact Ying TAM
A Novel Vaccine Approach Using Messenger RNA‐Lipid ... - YouTube
WEBIn this session from Vancouver Nanomedicine Day 2020, Dr. Ying Tam (Acuitas Therapeutics) discusses the development by Acuitas of lipid nanoparticle systems ...
Ying Tam - Acuitas Therapeutics - LinkedIn
WEBView Ying Tam’s profile on LinkedIn, a professional community of 1 billion members. Experienced Chief Scientific Officer with a demonstrated history of working in the biotechnology industry....
- 500+ connections
- Location: Acuitas Therapeutics
Ying Tam Ph.D Profile: Contact Information & Network - PitchBook
WEBDr. Ying Tam serves as Chief Scientific Officer at Acuitas Therapeutics. Dr. Ying K. Tam, is a globally respected expert in the areas of nanotechnology and immunology.
Acuitas Scientists Co-Author Nature Article - Acuitas
WEBAcuitas Therapeutics’ Chief Scientific Officer, Dr. Ying Tam, and Director of Formulation Development, Paulo Lin, co-authored (with several other scientists) a study titled …
Ying Tam | Integrated Nanotherapeutics | Canada - OMICS …
WEBDr. Ying Tam, co-founder of Integrated Nanotherapeutics, obtained his B.Sc., M.Sc. and Ph.D. in Biology from the University of Waterloo, Ontario.
Ying K. Tam | Acuitas Therapeutics | Canada - OMICS International
WEBAs a Senior Research Scientist at Tekmira Pharmaceuticals he oversaw the conduct of preclinical studies relating to development of immune-stimulating liposomal oligonucleotide products. Dr. Tam is an author on over 45 published or submitted scientific manuscripts.
Ying Tam (0000-0002-4083-5251) - ORCID
WEBEmployment. Show more detail. Source : Ying Tam. expand_more. Works (8) sort Sort. Immature dendritic cell-targeting mRNA vaccine expressing PfCSP enhances protective immune responses against Plasmodium liver infection. 2024-07-09 | Preprint. DOI: 10.21203/rs.3.rs-4656309/v1.
- Some results have been removed